Dr. Arsalan S. Haqqani is a Senior Research Officer at NRC and part of the Bioanalysis team, where he is using mass spectrometry-based methods to quantitatively demonstrate the delivery and efficacy of BBB-enabled therapeutics in brain parenchyma. He completed his Ph.D. at the University of Ottawa in the Department of Biochemistry, Microbiology and Immunology in the area of cancer research. In 2002, he joined the National Research Council of Canada (NRC) to develop mass spectrometry-based methods for antibody quantification and biomarker discovery, leading the Brain Beyond Barriers CARTA project, and integrated a genomic/proteomics map of various brain compartments, including the blood–brain barrier.